3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
13
Active not recruiting
11
Completed
8
Withdrawn
4
Terminated
4
Not yet recruiting
1
No longer available
1
Approved for marketing
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
1
Interventions
Trastuzumab
26
Carboplatin
20
pertuzumab
19
Paclitaxel
19
pyrotinib
17
Cyclophosphamide
17
Docetaxel
16
Capecitabine
16
trastuzumab deruxtecan
13
Radiotherapy
13
Drug Therapy
13
Standard of Care
12
Letrozole
12
Fulvestrant
12
dalpiciclib
11
pembrolizumab
10
exemestane
9
Specimen Handling
9
Epirubicin
9
Anastrozole
9
sacituzumab govitecan
8
palbociclib
8
eribulin
8
Neoadjuvant Therapy
7
Doxorubicin
7
130-nm albumin-bound paclitaxel
7
toripalimab
6
abemaciclib
6
Tamoxifen
6
Magnetic Resonance Spectroscopy
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
tucatinib
×
Breast
×
Clear all
NCT07494448
2026-04-23
JAZMINE
MedSIR
Phase 1/2
Not yet recruiting
24 enrolled